AMLODIPINE and OLMESARTAN medoxomil (Macleods Pharmaceuticals Limited)
Welcome to the PulseAid listing for the AMLODIPINE and OLMESARTAN medoxomil drug offered from Macleods Pharmaceuticals Limited. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Macleods Pharmaceuticals Limited |
| NON-PROPRIETARY NAME: | AMLODIPINE and OLMESARTAN medoxomil |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-27 |
| END MARKETING DATE: | 0000-00-00 |
AMLODIPINE and OLMESARTAN medoxomil HUMAN PRESCRIPTION DRUG Details:
| Item Description | AMLODIPINE and OLMESARTAN medoxomil from Macleods Pharmaceuticals Limited |
| LABELER NAME: | Macleods Pharmaceuticals Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 20(mg/1; mg/1) |
| START MARKETING DATE: | 2016-10-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 33342-190_fe631b31-e7a3-4ebf-a574-bd4a96710ff5 |
| PRODUCT NDC: | 33342-190 |
| APPLICATION NUMBER: | ANDA206884 |
Other AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL Pharmaceutical Manufacturers / Labelers:
